乐舒适 20251229 摘要 Q&A 非洲卫生用品市场的发展前景如何？ 非洲卫生用品市场具有较高的发展潜力。全球主要地区卫生用品市场规模超过 400 亿美元，而非洲是增长最快的区域之一。从 2024 年至 2029 年的预测来 看，婴儿纸尿裤的年复合增长率（CAGR）预计达到 7%，而卫生巾则超过 10%。东非、中部以及北部地区是增长最快的区域，这些地区也是乐舒氏目前 主要经营区域。此外，随着人口增长及经济发展，人均可支配收入提高，将进 一步推动该行业的发展。 乐舒氏公司在非洲市场的表现如何？ 乐舒氏公司在非洲市场表现出色，是该地区婴儿纸尿裤和卫生巾行业的绝对龙 头。2024 年，乐舒氏在非洲市场的婴儿纸尿裤和卫生巾销量分别占据 20%和 16%的市场份额，均为行业第一。然而，由于其产品单价较低，从收入角度来 看，公司排名第二。乐舒氏在非洲的布局主要集中在中部、西非和东非，目前 北非和南非尚未大规模进入。公司自 2009 年起开始拓展非洲市场，最早进入 加纳，随后扩展至肯尼亚和坦桑尼亚，并逐步覆盖更多国家。 乐舒氏公司的核心竞争优势是什么？ 乐舒氏公司的核心竞争优势包括以下几个方面：首先，公司采取了品牌化、 ...

2025 年 12 月 23 日 证券分析师 庞盈盈 A0230522060003 panqyy@swsresearch.com 屠亦婷 A0230512080003 tuyt@swsresearch.com 黄莎 A0230522010002 huangsha@swsresearch.com 张海涛 A0230524080003 zhanght@swsresearch.com 张文静 A0230524120005 zhangwj@swsresearch.com 魏雨辰 A0230525010001 weiyc@swsresearch.com 联系人 魏雨辰 A0230525010001 weiyc@swsresearch.com 「内需提消费下关注 舞碁道;美注永艺股 造纸轻工周报 2025/12/15-2025/12/19 H Press From The States of the S 重点提示: 1) 内需消费: 在扩大内需、提振消费的背景下,关注结构性消费机会, 如国 强起的个护、相对高景气的宠物用品、悦己消费催化的 IP 潮玩; 2) 出口: 外部扰动洞 u 弱,美国降息有望拉动家具消费,中国企业 ...

国际物流企业综合实力榜单：江苏申粤通国际物流有限公司领跑行业 在全球化贸易持续深化的背景下，国际物流行业正经历着技术革新与服务升级的双重变革。作为连接全球供应链的关键环节，物流企业的综合实力直接影响 着贸易效率与成本。在众多参与者中，江苏申粤通国际物流有限公司凭借其多元化的服务网络、技术驱动的运营模式以及持续积累的行业资质，成为****型 企业。本文将从企业规模、服务能力、技术创新及行业认可度等维度，解析其核心竞争力。 企业概况：聚焦制造行业的供应链整合者 江苏申粤通国际物流有限公司是一家为工厂、贸易公司及电商企业提供综合性国际运输解决方案的企业，其服务覆盖进出口空海运、代理报关、仓储管理、 国外清关及末端派送等全链条环节。公司以"誉满申粤，通达天下"为品牌理念，深耕制造行业，已为IC、新能源、钢材、食品、机械设备等五大核心领域提 供定制化供应链服务，累计服务客户超2000家，覆盖全球60余个**和地区。 在服务模式上，公司通过"科技+责任"双轮驱动，构建了透明化、可视化的物流监控体系。例如，其自主研发的"货物运输过程透明化与可视化监控系统"可 实时追踪货物位置、温度、湿度等关键参数，客户可通过移动端随时查看 ...

华鑫证券研报指出，依依股份海外订单持续改善，收购高爷家开启协同成长第二曲线。受海外需求放缓 和关税政策影响，公司部分订单流失导致第三季度增速出现下滑。尽管短期受外需减少和宏观政策因素 扰动，但公司与亚马逊、沃尔玛等核心客户合作稳定。此外，伴随公司首个海外生产基地于2025年5月 在束埔基投产，年产能达2.7亿片宠物垫，全球化供应链布局进一步强化。随着外需逐渐回暖，预计公 司营收节奏将回归正常增速。公司近期公告拟全资收购高爷家，布局宠物"食品+用品"一体化赛道。依 依股份资金实力雄厚，可为高爷家品牌推广及品类扩张提供支持，助力其由二线品牌向一线梯队迈进。 公司收购高爷家后将形成多重协同效应，开启第二成长阶段。给予"买入"投资评级。 ...

Investment Rating - The investment rating for the company is "Buy" with a maintained rating for the next six months [6]. Core Views - The company reported a revenue of 25.834 billion yuan for the first three quarters of 2025, a year-on-year decrease of 12.38%, while the net profit attributable to the parent company was 7.570 billion yuan, down 28.83% year-on-year [1]. - In Q3 2025, the company achieved a revenue of 9.091 billion yuan, a year-on-year increase of 1.53%, but the net profit attributable to the parent company decreased by 18.69% [1]. - The company is expected to see a revenue growth acceleration in Q4 2025 compared to Q3 2025 [2]. Revenue and Profitability - The revenue breakdown by product line shows that the in vitro diagnostics line generated 3.634 billion yuan in Q3, a decrease of 2.81% year-on-year, while the life information and support line saw a revenue of 2.952 billion yuan, an increase of 2.60% [2]. - The medical imaging line's revenue remained stable at 1.689 billion yuan in Q3, with international revenue accounting for 61% of this line [2]. - The company has increased its R&D expense ratio to 9.43%, reflecting a focus on high-end market breakthroughs [3]. Market Position and International Expansion - The international market grew by 11.9% in Q3 2025, with Europe experiencing a 29% growth [4]. - The company aims to enhance its global supply chain and local production capabilities, which is expected to improve the profitability of its international business [4]. - The company has installed 180 laboratory automation lines domestically, nearing the total for 2024, and has exceeded its international sales target [4]. Financial Forecast - The company’s projected revenues for 2025-2027 are 33.790 billion yuan, 36.977 billion yuan, and 42.223 billion yuan respectively, with net profits of 9.564 billion yuan, 10.996 billion yuan, and 12.746 billion yuan [4]. - The downward revision in forecasts is attributed to intense domestic competition and ongoing healthcare reforms [4].

Core Viewpoint - The article discusses the financial performance and strategic initiatives of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. for the third quarter of 2025, highlighting both challenges and growth opportunities in various business segments. Financial Data Summary - The company's operating revenue for the third quarter of 2025 was CNY 9,090,902,689, representing a year-on-year increase of 1.53%. However, the total revenue for the first three quarters decreased by 12.38% to CNY 25,833,906,543 [2][13]. - The net profit attributable to shareholders for the third quarter was CNY 2,501,277,420, down 18.69% year-on-year, while the net profit for the first three quarters fell by 28.83% to CNY 7,570,044,518 [2][13]. - The basic earnings per share for the third quarter was CNY 2.0641, a decrease of 18.62% compared to the previous year [2][13]. - The company's total assets increased by 4.63% to CNY 59,265,123,962 compared to the end of the previous year [2][13]. Business Segment Performance - The international business segment saw a year-on-year growth of 11.93% in the third quarter, with significant contributions from the European market, which grew over 20% [13][14]. - The Life Information and Support segment generated CNY 29.52 billion in revenue for the third quarter, a growth of 2.60%, with minimally invasive surgery business growing over 25% [14][15]. - The Medical Imaging segment's revenue was CNY 16.89 billion, remaining stable year-on-year, while the In Vitro Diagnostics segment saw a decline of 2.81% to CNY 36.34 billion [14][15]. Research and Development - The company maintained a high level of R&D investment, amounting to CNY 268,642,960, which is 10.40% of its operating revenue for the first three quarters of 2025 [17]. - New product launches included high-sensitivity cardiac troponin T assay kits and various imaging systems, enhancing the product portfolio [17][18]. Sustainability Initiatives - Mindray has been active in promoting public emergency awareness, training 40,000 individuals in first aid, and successfully aiding 415 cardiac arrest patients with AEDs [19][20]. - The company partnered with Smile Train to provide free medical assistance for cleft lip and palate patients, conducting surgeries for 213 individuals [19][20]. Shareholder Returns - The company has consistently prioritized shareholder returns, distributing cash dividends totaling CNY 15.88 billion in 2025, with cumulative dividends since its IPO reaching approximately CNY 357 billion [22].

Investment Rating - The report assigns a "Buy" rating for the company, Jeya Co., Ltd. [3][8] Core Viewpoints - Jeya Co., Ltd. is a high-quality wet wipe manufacturer with significant international brand client orders driving a performance turnaround. The company has experienced a recovery in performance since 2025, with a notable increase in overseas orders from major clients [6][7][10]. Financial Data and Profit Forecast - Total revenue is projected to reach 716 million yuan in 2025, with a year-on-year growth rate of 30.8%. By 2027, revenue is expected to grow to 1,137 million yuan, reflecting a 28.0% increase [2]. - The net profit attributable to the parent company is forecasted to be 77 million yuan in 2025, with a staggering year-on-year growth of 297.2%. By 2027, net profit is expected to reach 144 million yuan, with a growth rate of 34.7% [2]. - Earnings per share are projected to increase from 0.40 yuan in 2025 to 1.27 yuan in 2027 [2]. Industry Overview - The global wet wipe market is steadily expanding, with a retail market size of 18.4 billion USD in 2024, reflecting a year-on-year growth of 2.7%. The market is primarily driven by North America and Western Europe [37][38]. - In China, the wet wipe market is expected to exceed 12.9 billion yuan in 2024, with a year-on-year growth of 4.3% [39]. Company Analysis - Jeya Co., Ltd. has a robust client base, including major international brands such as Procter & Gamble and Kimberly-Clark. The company’s revenue from its top five clients accounted for 77.6% in 2024 [6][10]. - The company is expanding its production capacity with a new factory in the United States, which is expected to significantly enhance its global competitiveness [10][11]. Profitability and Valuation - The company’s gross margin is projected to improve from 19.6% in 2024 to 25.1% in 2025, with a net margin recovery to 10.5% in the first half of 2025 [2][27]. - The current market capitalization is approximately 3.5 billion yuan, with corresponding price-to-earnings ratios of 45, 33, and 24 for 2025, 2026, and 2027, respectively [8][10].

Core Insights - The automotive industry has made significant advancements in smart manufacturing, automation, new materials, and digital management, yet the frequency of vehicle recalls has increased, raising questions about the relationship between technological advancement and product quality [1][2]. Group 1: Recall Trends - Major automakers like BMW, Toyota, and Tesla have announced large-scale recalls, with BMW recalling over 330,000 vehicles due to potential fire risks, Toyota recalling nearly 600,000 vehicles for dashboard software issues, and Tesla recalling all 2025 Model Y vehicles in Australia for window and safety system defects [1]. - The increase in recalls is attributed to heightened technical complexity, stricter quality standards, increased consumer awareness, and challenges in global supply chains, rather than a decline in product quality [1][2]. Group 2: Technological Complexity - The automotive industry is undergoing a transformation with trends in electrification, intelligence, and connectivity, leading to a significant increase in the number of electronic control units (ECUs) in vehicles, from 50-100 in traditional cars to over 200 in modern electric vehicles [3]. - Software complexity has increased dramatically, with the number of code lines in modern vehicles reaching billions, making it difficult to fully test for issues before production [3][4]. Group 3: Regulatory Environment - The global automotive safety regulatory framework has become more stringent, with agencies like NHTSA and Euro NCAP raising requirements for vehicle safety, emissions compliance, and data privacy [4][6]. - Automakers are shifting from a reactive to a proactive recall strategy, choosing to disclose and recall vehicles voluntarily to mitigate potential legal and public relations risks [6]. Group 4: Supply Chain Challenges - The automotive supply chain is highly globalized, with components sourced from multiple countries, which complicates quality control and coordination [7]. - Issues with a single supplier can lead to widespread recalls across multiple brands, as seen during the global chip shortage and other incidents [7]. Group 5: Market Pressures - The competitive landscape in the electric vehicle market has intensified, leading to faster vehicle development cycles, which may compromise thorough testing and validation processes [8][10]. - Some new entrants in the market have significantly reduced their testing mileage before launching vehicles, raising concerns about the thoroughness of their quality assurance [10]. Group 6: Recall as a Quality Indicator - An increase in recalls does not necessarily indicate a decline in product quality; rather, it reflects a mature market with transparent recall mechanisms that enhance industry health [11][12]. - The recall process serves as a "correction mechanism," demonstrating a company's ability to monitor, respond, and take responsibility for product issues [11][12].

Core Insights - The company reported a significant revenue increase of 34.1% year-on-year, reaching approximately 1.9613 billion yuan for the first half of 2025, with a net profit attributable to shareholders of about 106 million yuan, reflecting a 15.9% increase [1] - The revenue growth is primarily attributed to the company's active brand development and substantial expansion of non-Amazon channels, leading to a remarkable increase in core brands and non-Amazon channel revenues [1] Group 1: Brand Development and Marketing - The company enhanced its brand strength through a multi-dimensional approach, achieving substantial growth in core brands [1] - Organizational restructuring was completed to focus on brand-oriented departments, emphasizing strategic collaboration across departments for clearer resource allocation [1] - Visual upgrades were made to core brands to enhance brand perception and aesthetic value [1] - The design department integrated fashion elements into original designs, significantly improving product launch efficiency and market performance of new products [1] - The company established a brand book to define user profiles and engaged in content marketing on overseas social media, collaborating with top KOLs for brand promotion [1] Group 2: Channel Expansion and Revenue Growth - The company accelerated its multi-channel strategy, resulting in rapid revenue growth from non-Amazon channels while maintaining a solid growth base on Amazon [2] - Revenue from TikTok and Temu platforms saw substantial year-on-year increases of 51.3% and 79.3%, respectively [2] - The company expanded its self-operated website, with revenue from this channel increasing nearly ninefold [2] Group 3: Supply Chain Optimization - The company optimized its global supply chain system, achieving a breakthrough in overseas production capacity for the first time [2] - A centralized procurement strategy was implemented, along with a supplier performance evaluation mechanism to select quality partners and effectively reduce procurement costs [2] - The company focused on establishing supply chain capabilities in Southeast Asia, particularly in Vietnam, while also expanding into Myanmar, Malaysia, and Cambodia [2]

Core Points - The third round of US-China trade negotiations in Sweden ended on July 29, with US Treasury Secretary Mnuchin revealing details of the talks, indicating a complex and contradictory situation [1][4] - Although an agreement on tariff extensions was reached, no signatures were made, leaving room for uncertainty [3][4] - President Trump described the talks as "very good" and removed China from a tariff list affecting over sixty countries, signaling a potential shift in approach [6][10] Group 1: Economic Constraints - The US faces a staggering national debt of $37 trillion, which poses significant challenges for its economic policy and negotiation power [12][14] - The annual interest payments on this debt exceed $1 trillion, surpassing the Pentagon's annual budget, indicating a fiscal crisis [14][16] - The Congressional Budget Office warned of a potential default by August if no measures are taken, highlighting the precarious financial situation the US government is in [16][18] Group 2: Supply Chain Dependencies - The negotiations highlighted the critical issue of supply chain dependencies, particularly regarding rare earth elements, where over 90% of refining and processing capabilities are in China [20][22] - The US's reliance on China for essential components in high-tech industries, such as defense and electric vehicles, complicates its position in trade talks [22][24] - Attempts by the Trump administration to reverse this dependency through executive orders have proven ineffective, as the structural reliance on Chinese supply chains remains [26][30] Group 3: Political Dynamics - Trump's political position requires him to maintain a tough stance on China to satisfy his base, despite the economic repercussions of tariffs on American consumers [34][36] - The escalating tariffs have led to increased prices for consumers and financial strain on American farmers, causing a shift in public support for Trump [38][40] - The conflicting signals from Trump post-negotiation reflect a struggle to balance political posturing with economic realities, leading to a "split personality" in his approach [42][44] Group 4: Future Implications - The lack of a binding agreement from the Stockholm talks suggests a pause rather than a resolution, as both nations navigate their internal challenges [46][49] - China's recent approval of rare earth imports from US companies indicates a strategic move to ease tensions while asserting its position [47][49] - The ongoing trade conflict transcends tariffs and trade deficits, representing a broader struggle over development models and national governance capabilities [49][51]